Retraction notice to: "LncRNA PVT1 facilitates tumorigenesis and progression of Glioma via regulation of MiR-128-3p/GREM1 Axis and BMP signaling pathway" Neurotherapeutics 15 (4) 2018 1139-1157.

IF 5.6 2区医学 Q1 CLINICAL NEUROLOGY Neurotherapeutics Pub Date : 2024-10-01 Epub Date: 2024-09-28 DOI:10.1016/j.neurot.2024.e00449

Chao Fu, Dongyuan Li, Xiaonan Zhang, Naijie Liu, Guonan Chi, Xingyi Jin

引用次数: 0

查看原文

微信好友朋友圈 QQ好友复制链接

本刊更多论文

撤稿通知："LncRNA PVT1 通过调控 MiR-128-3p/GREM1 Axis 和 BMP 信号通路促进胶质瘤的肿瘤发生和进展》 Neurotherapeutics 15 (4) 2018 1139-1157.

本文章由计算机程序翻译，如有差异，请以英文原文为准。

求助全文

约1分钟内获得全文去求助

来源期刊

Neurotherapeutics 医学-神经科学

CiteScore

11.00

自引率

3.50%

发文量

154

审稿时长

6-12 weeks

期刊介绍： Neurotherapeutics® is the journal of the American Society for Experimental Neurotherapeutics (ASENT). Each issue provides critical reviews of an important topic relating to the treatment of neurological disorders written by international authorities. The Journal also publishes original research articles in translational neuroscience including descriptions of cutting edge therapies that cross disciplinary lines and represent important contributions to neurotherapeutics for medical practitioners and other researchers in the field. Neurotherapeutics ® delivers a multidisciplinary perspective on the frontiers of translational neuroscience, provides perspectives on current research and practice, and covers social and ethical as well as scientific issues.